Gelonghui reported on December 26 that Shengnuo Bio (688117.SH) stated on the investor interaction platform that the Active Pharmaceutical Ingredient and injection project for Semaglutide is currently in the pharmaceutical research stage, and the Active Pharmaceutical Ingredient for Semaglutide has been filed with the USA FDA. The project for the Active Pharmaceutical Ingredient and formulation of Teriparatide is also currently in the pharmaceutical research stage.
圣诺生物(688117.SH)：替尔泊肽原料药及制剂项目目前正处于药学研究阶段
Shengnuo Bio (688117.SH): The project for Teirbo peptide Active Pharmaceutical Ingredient and formulation is currently in the pharmaceutical research stage.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney